Honing In On Value At Citicorp Healthcare Conference
The value of medicine was a key theme at Citigroup’s Global Healthcare conference in New York, where top executives from Bristol, Sanofi, Pfizer and Lilly, including J&J’s CEO Alex Gorsky participated in Q&As with analysts and attendees.
You may also be interested in...
More than a dozen new molecular entities launched for the treatment of cancer in 2012, advancing care for seriously ill people, but many carry price tags of $100,000 per year or more for treatment, escalating debate over cost of care and how best to direct limited healthcare resources.
Over the last two years, UnitedHealthcare and Aetna have launched cancer pathway programs with the overall goals of standardizing and improving care and lowering cost. Drug therapy is a key focus.
Looking Ahead To 2012: ACOs Get In Gear, Accelerating The Need to Prove Biopharma Products' Overall Value In Health Care
Thirty-two "Pioneer" accountable care organizations began operations with the new year.